“Silent Spring” revisited: Implications for breast cancer care
sponsorship: AT: Johnson & Johnson, Bristol-Myer Squib, Pfizer, Gilead Sciences (stock ownership) ; Delphi Diagnostics, RTI international, Accord Bio-Pharma (consulting) ; Up-to-Date (royalties) . (Johnson Johnson, Bristol-Myer Squib, Pfizer, Gilead Sciences, RTI international, Accord Bio-Pharma, Up-to-Date)
Authors
- Alexandra Thomas (ORCID: https://orcid.org/0000-0003-2754-721X)
- Seamus O’Reilly (ORCID: https://orcid.org/0000-0002-1873-450X)
- Hans Wildiers (ORCID: https://orcid.org/0000-0001-8990-7837)
Institutions
- Royal College of Surgeons in Ireland (IE)
- Duke University (US)
- KU Leuven (BE)
Publication Details
- Journal
- The Breast
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1016/j.breast.2025.104643
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00